Current News:

• Bioject to Report Second Quarter 2010 Financial Results

• Bioject’s Intradermal Needle-Free Delivery System Used in World Health Organization Clinical Trial in Oman with Poliovirus Vaccine

• Bioject Announces Results of Intradermal Dose Sparing Influenza Study Conducted by the Centers for Disease Control and Prevention

• Bioject Announces Results from US Navy Study for a Malaria Vaccine

• Bioject Meets Final Development Milestone for Merial Ltd

• Cyto Pulse, the Karolinska Institute and the Swedish Institute for Infectious Disease Control Receive Phase I Clinical Trial Approval from the Swedish Medical Products Agency to Evaluate an HIV Vaccine in Healthy Volunteers

• MERIAL Receives Full License Approval for ONCEPT(TM) Canine Melanoma Vaccine

• Bioject Establishes Strategic Alliance with MPI Research